Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea
- 1 October 2005
- journal article
- case report
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 17 (10) , 1135-1137
- https://doi.org/10.1097/00042737-200510000-00021
Abstract
Despite an ancient reputation for potential phytotherapeutic effects and innocuity, traditional herbal medicine has previously been implicated in severe adverse events. Exolise is an 80% ethanolic dry extract of green tea (Camellia sinensis) standardized at 25% catechins expressed as epigallocatechin gallate, containing 5-10% caffeine. It has been available in France, Belgium, Spain and the United Kingdom since 1999, as an adjuvant therapy for use in weight loss programmes. In various studies, green tea has to date been considered useful for its potential hepatic protective properties. In this study, we report a case of fulminant hepatitis during self-medication with Exolise, requiring liver transplantation.Keywords
This publication has 8 references indexed in Scilit:
- Hépatotoxicité probable du gallate d’épigallocatéchol utilisé en phytothérapieGastroentérologie Clinique Et Biologique, 2004
- Green Tea Extract Protects against Early Alcohol-Induced Liver Injury in RatsBiological Chemistry, 2002
- Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesityPhytomedicine, 2002
- Effect of Potassium Sorbate on Cellular GSH Level and Lipid Peroxidation in Cultured Rat Hepatocytes.Biological & Pharmaceutical Bulletin, 1998
- Protective Effect of Green Tea Extract and Tea Polyphenols against the Cytotoxicity of 1,4-Naphthoquinone in Isolated Rat HepatocytesBioscience, Biotechnology, and Biochemistry, 1997
- Hepatotoxicity of SaccharinNew England Journal of Medicine, 1994
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993
- Piribedil in Parkinson's syndrome: A clinical studyEuropean Journal of Clinical Pharmacology, 1975